S.No. |
Title |
Source Title |
Authors |
DOI |
Citing Works Count |
1 |
Risk factors for the Pap test cytological changes in Iran: A multicenter case-control study
|
Current Womens Health Reviews
|
Gita Sangestani; Greco Pantaleo; Ali Reza Soltanian; Mahnaz Khatiban
|
10.2174/1573404817666210105143335
|
0
|
2 |
Novel Therapeutic Approaches and Targets for Treatment of Vulvar Lichen Sclerosus.
|
Current Pharmaceutical Biotechnology
|
Alessandro Borghi; Monica Corazza
|
10.2174/1389201021666200516154310
|
0
|
3 |
Italian Association of Clinical Endocrinologists (AME) and Italian AACE Chapter Position Statement for Clinical Practice: Acromegaly - Part 1: Diagnostic and Clinical Issues.
|
Endocrine, Metabolic & Immune Disorders Drug Targets
|
Renato Cozzi; Maria Rosaria Ambrosio; Roberto Attanasio; Alessandro Bozzao; Laura De Marinis; Ernesto De Menis; Edoardo Guastamacchia; Andrea Lania; Giovanni Lasio; F Logoluso; Pietro Maffei; Maurizio Poggi; Vincenzo Toscano; Michele Zini; Philippe Chanso
|
10.2174/1871530320666200127103320
|
0
|
4 |
Italian Association of Clinical Endocrinologists (AME) and Italian AACE Chapter Position Statement for Clinical Practice: Acromegaly - Part 2: Therapeutic Issues
|
Endocrine, Metabolic & Immune Disorders Drug Targets
|
Renato Cozzi; Maria Rosaria Ambrosio; Roberto Attanasio; Alessandro Bozzao; Laura De Marinis; Ernesto De Menis; Edoardo Guastamacchia; Andrea Lania; Giovanni Lasio; F Logoluso; Pietro Maffei; Maurizio Poggi; Vincenzo Toscano; Michele Zini; Philippe Chanso
|
10.2174/1871530320666200129113328
|
1
|
5 |
Application of Artificial Intelligence in Targeting Retinal Diseases.
|
Current Drug Targets
|
Francesco Sorrentino; Giuseppe Jurman; Katia De Nadai; Claudio Campa; Cesare Furlanello; Francesco Parmeggiani
|
10.2174/1389450121666200708120646
|
1
|
6 |
Glioblastoma: Prognostic Factors and Predictive Response to Radio and Chemotherapy.
|
Current Medicinal Chemistry
|
Francesco Fiorica; Maria Colella; R Taibi; Andrea Bonetti; Jacopo Giuliani; Maria Sole Perrone; Sonia Missiroli; Carlotta Giorgi
|
10.2174/0929867327666200131095256
|
0
|
7 |
Meet Our Editorial Board Member
|
Letters In Drug Design & Discovery
|
Romeo Romagnoli
|
10.2174/157018081705200403080300
|
0
|
8 |
Toward the Discovery and Development of PSMA Targeted Inhibitors for Nuclear Medicine Applications
|
Current Radiopharmaceuticals
|
Sara Pastorino; Mattia Riondato; Licia Uccelli; Giampiero Giovacchini; Elisabetta Giovannini; Valerio Duce; Andrea Ciarmiello
|
10.2174/1874471012666190729151540
|
6
|
9 |
Meet Our Editorial Board Member
|
Recent Patents On Inflammation & Allergy Drug Discovery
|
Alberto Papi
|
10.2174/1872213x1302191122123948
|
0
|
10 |
Structure Activity Relationship of 4-Amino-2-thiopyrimidine Derivatives as Platelet Aggregation Inhibitors
|
Medicinal Chemistry (Shariqah (United Arab Emirates))
|
Barbara Cacciari; Pamela Crepaldi; Chun Yan Cheng; Elena Bossi; Giampiero Spalluto; Stephanie Federico; Kenneth A. Jacobson; Marco Cattaneo
|
10.2174/1573406415666190208124534
|
1
|
11 |
Lipid Nanoparticles and Active Natural Compounds: A Perfect Combination for Pharmaceutical Applications.
|
Current Medicinal Chemistry
|
Carmelo Puglia; Rosario Pignatello; Virginia Fuochi; Pio Maria Furneri; Maria Rosaria Lauro; Debora Santonocito; Rita Cortesi; Elisabetta Esposito
|
10.2174/0929867326666190614123835
|
5
|
12 |
Nanomedicines to Treat Skin Pathologies with Natural Molecules
|
Current Pharmaceutical Design
|
Elisabetta Esposito; Claudio Nastruzzi; Maddalena Sguizzato; Rita Cortesi
|
10.2174/1381612825666190709210703
|
6
|
13 |
Drug Release from Pharmaceutical Co-Crystals: Are Therapeutic and Safety Properties of Active Pharmaceutical Substances Retained?
|
Current Drug Delivery
|
Alessandro Dalpiaz; Valeria Ferretti; Giada Botti; Barbara Pavan
|
10.2174/156720181606190723115802
|
0
|
14 |
New Strategies for the Delivery of Some Natural Anti-oxidants with Therapeutic Properties.
|
Mini Reviews In Medicinal Chemistry
|
Elisabetta Esposito; Markus Drechsler; Carmelo Puglia; Rita Cortesi
|
10.2174/1389557519666190228160242
|
4
|
15 |
Clinical Management of Oral Lichen Planus: A Systematic Review
|
Mini Reviews In Medicinal Chemistry
|
Luca Oberti; Lucchese Alberta; Petruzzi Massimo; Carinci Francesco; Lauritano Dorina
|
10.2174/1389557519666190301144157
|
4
|
16 |
Eyelid Dermatitis and Contact Sensitization to Nickel: Results from an Italian Multi-Centric Observational Study.
|
Endocrine, Metabolic & Immune Disorders Drug Targets
|
Alessandro Borghi; Monica Corazza; Elisa Maietti; Cataldo Patruno; Maddalena Napolitano; Donatella Schena; Maria Letizia Musumeci; Giuseppe Micali; Thea Magrone; Paolo Romita; Caterina Foti
|
10.2174/1871530318666180731114418
|
2
|
17 |
Regenerative Dentistry and Stem Cells: A Multilineage Differentiation as a Safe and Useful Alternative Way of Harvesting and Selection Adipose Derived Mesenchymal Stem Cells
|
Current Drug Targets
|
Dorina Lauritano; Annalisa Palmieri; Valentina Candotto; Francesco Carinci
|
10.2174/1389450119666180816122230
|
1
|
18 |
Cerebral Inflow and Outflow Discrepancies in Severe Sudden Sensorineural Hearing Loss.
|
Current Neurovascular Research
|
Andrea Ciorba; Mirko Tessari; Manuela Mazzoli; Valentina Tavoni; Francesco Sisini; Claudia Aimoni; Francesco Stomeo; Erica Menegatti; Stefano Pelucchi; Paolo Zamboni
|
10.2174/1567202615666180727091955
|
2
|
19 |
Production and Characterization of Nanoparticle Based Hyaluronate Gel Containing Retinyl Palmitate for Wound Healing
|
Current Drug Delivery
|
Elisabetta Esposito; Alessandra Pecorelli; Maddalena Sguizzato; Markus Drechsler; Paolo Mariani; Federica Carducci; Franco Cervellati; Claudio Nastruzzi; Rita Cortesi; Giuseppe Valacchi
|
10.2174/1567201815666180518123926
|
5
|
20 |
Automated Synthesis of 68Ga-DOTA-TOC with a Cationic Purification System: Evaluation of Methodological and Technical Aspects in Routine Preparations.
|
Current Radiopharmaceuticals
|
Licia Uccelli; Alessandra Boschi; Corrado Cittanti; Petra Martini; Luca Lodi; Elisa Zappaterra; Simona Romani; S. Zaccaria; Davide Cecconi; Ilaria Rambaldi; Ivan Santi; Stefano Panareo; Melchiore Giganti; Mirco Bartolomei
|
10.2174/1874471011666180509101420
|
3
|
21 |
Nanodiagnostics and Nanodelivery Applications in Genetic Alterations.
|
Current Pharmaceutical Design
|
Maria Sofia Falzarano; Cristina Flesia; Roberta Cavalli; Caterina Guiot; Alessandra Ferlini
|
10.2174/1381612824666180110151318
|
3
|
22 |
A2A Adenosine Receptor Antagonists as Therapeutic Candidates: Are They Still an Interesting Challenge?
|
Mini Reviews In Medicinal Chemistry
|
Barbara Cacciari; Giampiero Spalluto; Stephanie Federico
|
10.2174/1389557518666180423113051
|
10
|
23 |
Emerging Roles of Purinergic Signaling in Diabetes.
|
Medicinal Chemistry (Shariqah (United Arab Emirates))
|
Carmen Fotino; Diego Dal Ben; Elena Adinolfi
|
10.2174/1573406414666180226165204
|
9
|
24 |
Drug-Coated Balloons Applications in Interventional Cardiology.
|
Current Pharmaceutical Design
|
Gianluca Rigatelli; Marco Zuin
|
10.2174/1381612824666171227212112
|
0
|
25 |
High Resolution M-mode Evaluation of Jugular Vein Valves in Patients with Neurological and Neurosensory Disorders.
|
Current Neurovascular Research
|
Erica Menegatti; Mirko Tessari; Maria Elena Vannini; Sergio Gianesini; Anna Maria Malagoni; Andrea Ciorba; Manuela Mazzoli; Francesco Sisini; Fabrizio Salvi; Stefano Pelucchi; Paolo Zamboni
|
10.2174/1567202614666171005122150
|
4
|
26 |
Risk for Depression, Burnout and Low Quality of Life Among Personnel of a University Hospital in Italy is a Consequence of the Impact One Economic Crisis in the Welfare System?
|
Clinical Practice And Epidemiology In Mental Health : CP & EMH
|
Carta; Antonio Preti; Igor Portoghese; E Pisanu; Daniela Moro; Mirra Pintus; Elisa Pintus; Alessandra Perra; Silvia D’Oca; Michela Atzeni; Marcello Campagna; E Fabrici Pascolo; Federica Sancassiani; Gabriele Finco; Ernesto D'Aloja; Luigi Grassi
|
10.2174/1745017901713010156
|
8
|
27 |
Treatment and Response to Statins: Gender-related Differences.
|
Current Medicinal Chemistry
|
Valeria Raparelli; Gaetano Pannitteri; Tommaso Todisco; Filippo Toriello; Laura Napoleone; Roberto Manfredini; Stefania Basili
|
10.2174/0929867324666161118094711
|
12
|
28 |
P2X7 receptor orchestrates multiple signalling pathways triggering inflammation, autophagy and metabolic/trophic responses.
|
Current Medicinal Chemistry
|
Elisa Orioli; Elena De Marchi; Anna Lisa Giuliani; Elena Adinolfi
|
10.2174/0929867324666170303161659
|
45
|
29 |
Chiral Ligand-Exchange Chromatography of Pharmaceutical Compounds on Dynamically Coated (Home-Made) Stationary Phases.
|
Current Medicinal Chemistry
|
Maurizio Remelli
|
10.2174/0929867323666160627121629
|
2
|
30 |
Personalized Medicine in the Paediatric Population: The Balance Between Pharmacogenetic Progress and Bioethics
|
Current Pharmaceutical Biotechnology
|
Stefania Schiavone; Margherita Neri; Cristoforo Pomara; Irene Riezzo; Luigia Trabace; Emanuela Turillazzi
|
10.2174/1389201018666170207130236
|
6
|
31 |
Critical Roles of EGFR Family Members in Breast Cancer and Breast Cancer Stem Cells: Targets for Therapy.
|
Current Pharmaceutical Design
|
Linda S. Steelman; Timothy L. Fitzgerald; Kvin Lertpiriyapong; Lucio Cocco; Matilde Y. Follo; Alberto M. Martelli; Luca M. Neri; Sandra Marmiroli; Massimo Libra; Saverio Candido; Ferdinando Nicoletti; Aurora Scalisi; Concettina Fenga; Lyudmyla Drobot; Dar
|
10.2174/1381612822666160304151011
|
25
|
32 |
Antitubulinic effect of New Fluorazone Derivatives on Melanoma Cells.
|
Anti-cancer Agents In Medicinal Chemistry
|
Claudia Sticozzi; Francesca Aiello; Rita Bassi Andreasi; Ximena M. Muresan; Giuseppe Belmonte; Franco Cervellati; Emilia Maellaro; Emanuela Maioli; Giuseppe Valacchi
|
10.2174/1871520615666150909120014
|
4
|
33 |
Coagulation Factor XIIIA (F13A1): Novel Perspectives in Treatment and Pharmacogenetics
|
Current Pharmaceutical Design
|
Donato Gemmati; Marco Vigliano; Francesco Burini; Rosella Mari; Hodeib Hossam Abd El Mohsein; Francesco Parmeggiani; Maria Luisa Serino
|
10.2174/1381612822666151210122954
|
15
|
34 |
Anti-VEGF Therapy for Retinal Vein Occlusions
|
Current Drug Targets
|
Claudio Campa; Giuseppe Alivernini; Elena Bolletta; Maurizio Battaglia Parodi; Paolo Perri
|
10.2174/1573399811666150615151324
|
34
|
35 |
Chemistry and bifunctional chelating agents for binding (177)Lu.
|
Current Radiopharmaceuticals
|
Jozef L. Parus; Dariusz Pawlak; Renata Mikolajczak; Adriano Duatti
|
10.2174/1874471008666150312160440
|
10
|
36 |
Therapeutic Effects of Vitamin D in Asthma and Allergy.
|
Mini Reviews In Medicinal Chemistry
|
Cecilia Benetti; Pasquale Comberiati; Carlo Capristo; Attilio L. Boner; Diego Peroni
|
10.2174/1389557515666150519110640
|
6
|
37 |
Synthesis and Biological Evaluation of Pyrazolo[3,4-b]pyridin-4-ones as a New Class of Topoisomerase II Inhibitors.
|
Medicinal Chemistry (Shariqah (United Arab Emirates))
|
Mojgan Aghazadeh Tabrizi; Pier Giovanni Baraldi; Stefania Baraldi; Filippo Prencipe; Delia Preti; Giulia Saponaro; Romeo Romagnoli; Stefania Gessi; Stefania Merighi; Angela Stefanelli; Debora Fazzi; Pier Andrea Borea; Rodolfo C. outo Maia; Nelilma C. Rome
|
10.2174/1573406411666141210141317
|
3
|
38 |
Emerging roles of P2X receptors in cancer.
|
Current Medicinal Chemistry
|
Elena Adinolfi; Marina Capece; Francesca Amoroso; Elena De Marchi; Alessia Franceschini
|
10.2174/0929867321666141012172913
|
38
|
39 |
P2X receptors and inflammation.
|
Current Medicinal Chemistry
|
Francesco Di Virgilio
|
10.2174/0929867322666141210155311
|
55
|
40 |
A Comparison of Shear Bond Strength of Ceramic and Resin Denture Teeth on Different Acrylic Resin Bases
|
The Open Dentistry Journal
|
Massimo Corsalini; Daniela Di Venere; Francesco Pettini; G. Stefanachi; Santo Catapano; Antonio Boccaccio; Luciano Lamberti; Carmine Pappalettere; Stefano Carossa
|
10.2174/1874210601408010241
|
8
|
41 |
Synthesis and evaluation of indole based molecules for treatment of oxidative stress related diseases
|
Current Topics In Medicinal Chemistry
|
Francesca Aiello; Giuseppe Valacchi
|
10.2174/1568026614666141203142926
|
5
|
42 |
Editorial (Thematic Issue: Purinergic P2X Receptors: Physiological and Pathological Roles and Potential as Therapeutic Targets)
|
Current Medicinal Chemistry
|
Diego Dal Ben; Elena Adinolfi
|
10.2174/092986732207150202151642
|
5
|
43 |
Neurotensin NTS1-Dopamine D2 Receptor-Receptor Interactions in Putative Receptor Heteromers: Relevance for Parkinson`s Disease and Schizophrenia
|
Current Protein & Peptide Science
|
Luca Ferraro; Sarah Beggiato; Dasiel O. Borroto-Escuela; Laura Ravani; William T. O'Connor; Maria Cristina Tomasini; Andrea Celeste Borelli; Luigi F. Agnati; Tiziana Antonelli; Sergio Tanganelli; Kjell Fuxe
|
10.2174/1389203715666140901105253
|
19
|
44 |
Adenosine A2A-D2 receptor-receptor interactions in putative heteromers in the regulation of the striato-pallidal gaba pathway: possible relevance for parkinson's disease and its treatment.
|
Current Protein & Peptide Science
|
Sarah Beggiato; Tiziana Antonelli; Maria Cristina Tomasini; Andrea Celeste Borelli; Luigi F. Agnati; Sergio Tanganelli; Kjell Fuxe; Luca Ferraro
|
10.2174/1389203715666140901103205
|
14
|
45 |
Synthesis of a Novel Class of gem-Phosphonate-Phosphates by Reductive Cleavage of the Isoxazolidine Ring
|
Current Organic Synthesis
|
Olga Bortolini; Iqbal Mulani; Antonio De Nino; Loredana Maiuolo; Alessandro Melicchio; Beatrice Russo; Donatella Granchi
|
10.2174/15701794113109990061
|
6
|
46 |
Copper chelators: chemical properties and bio-medical applications.
|
Current Medicinal Chemistry
|
Matteo Tegoni; Daniela Valensin; L. Toso; Maurizio Remelli
|
10.2174/0929867321666140601161939
|
29
|
47 |
Assessment of Mobility Status and Risk of Mobility Disability in Older Persons
|
Current Pharmaceutical Design
|
E. Savino; Stefano Volpato; Giovanni Zuliani; Jack M. Guralnik
|
10.2174/13816128113196660684
|
10
|
48 |
Human Internal Jugular Valve M-mode Ultrasound Characterization
|
Current Neurovascular Research
|
Erica Menegatti; Mirko Tessari; Sergio Gianesini; Maria Elena Vannini; Francesco Sisini; Paolo Zamboni
|
10.2174/1567202611666140408094014
|
11
|
49 |
Mixed tridentate π -donor and monodentate π -acceptor ligands as chelating systems for rhenium-188 and technetium-99m nitrido radiopharmaceuticals.
|
Current Radiopharmaceuticals
|
Alessandra Boschi; Licia Uccelli; Micol Pasquali; Roberto Pasqualini; Remo Guerrini; Adriano Duatti
|
10.2174/18744710113069990022
|
16
|
50 |
Chemokines and chemokine receptors blockers as new drugs for the treatment of chronic obstructive pulmonary disease.
|
Current Medicinal Chemistry
|
Gaetano Caramori; A. Di Stefano; Paolo Casolari; Paul Kirkham; Anna Padovani; Kian Fan Chung; Alberto Papi; Ian M. Adcock
|
10.2174/09298673113206660261
|
20
|
51 |
Oxaliplapin and capecitabine (XELOX) based chemotherapy in the treatment of metastatic colorectal cancer: the right choice in elderly patients.
|
Anti-cancer Agents In Medicinal Chemistry
|
Massimiliano Berretta; Giuseppe Aprile; Guglielmo Nasti; Martina Urbani; Alessandra Bearz; Stefania Eufemia Lutrino; Luisa Foltran; Laura Ferrari; Renato Talamini; Francesco Fiorica; Arben Lleshi; Vincenzo Canzonieri; Chiara Lestuzzi; Eugenio Borsatti; Fi
|
10.2174/18715206113136660347
|
11
|
52 |
Free Radicals and Antioxidants: How to Reestablish Redox Homeostasis in Chronic Diseases?
|
Current Medicinal Chemistry
|
V. Bocci; Giuseppe Valacchi
|
10.2174/0929867311320270005
|
30
|
53 |
The new compound GET73, N-[(4-trifluoromethyl)benzyl]4-methoxybutyramide, Regulates hippocampal Aminoacidergic transmission possibly via an allosteric modulation of mGlu5 receptor. Behavioural evidence of its "anti-alcohol" and anxiolytic properties.
|
Current Medicinal Chemistry
|
Luca Ferraro; Antonella Loche; Sarah Beggiato; Maria Cristina Tomasini; Tiziana Antonelli; Gaia Colombo; Carla Lobina; Mauro A. M. Carai; Alessandra Porcu; Maria Paola Castelli; Francesca Clerici; Andrea Celeste Borelli; Roberto Cacciaglia; Sergio Tangane
|
10.2174/09298673113209990167
|
6
|
54 |
Nanoparticles loaded with Nutlin-3 display cytotoxicity towards p53(wild-type) JVM-2 but not towards p53(mutated) BJAB leukemic cells.
|
Current Medicinal Chemistry
|
Rebecca Voltan; Paola Secchiero; Barbara Ruozi; L. Caruso; Flavio Forni; M. Palomba; Giorgio Zauli; Maria Angela Vandelli
|
10.2174/0929867311320210007
|
10
|
55 |
Systemic oxidative stress in older patients with mild cognitive impairment or late onset Alzheimer's disease
|
Current Alzheimer Research
|
Carlo Cervellati; Eleonora Cremonini; Cristina Bosi; Stefania Magon; Amedeo Zurlo; Carlo M. Bergamini; Giovanni Zuliani
|
10.2174/1567205011310040003
|
59
|
56 |
MDM2 non-genotoxic inhibitors as innovative therapeutic approaches for the treatment of pediatric malignancies.
|
Current Medicinal Chemistry
|
Veronica Tisato; Alessia Norcio; Rebecca Voltan; Claudio Celeghini; Davide Zella; Paola Secchiero
|
10.2174/0929867311320170007
|
4
|
57 |
Potential role of TRAIL in the management of autoimmune diabetes mellitus.
|
Current Pharmaceutical Design
|
Stella Bernardi; Alessia Norcio; Barbara Toffoli; Giorgio Zauli; Paola Secchiero
|
10.2174/138161212803530925
|
8
|
58 |
New insights into HLA-G and inflammatory diseases.
|
Inflammation & Allergy Drug Targets
|
Roberta Rizzo; Daria Bortolotti; Olavio R. Baricordi; Enrico Fainardi
|
10.2174/187152812803590037
|
30
|
59 |
State of the Art of the Therapeutic Perspective of Sorafenib Against Hematological Malignancies
|
Current Medicinal Chemistry
|
Giorgio Zauli; Rebecca Voltan; Veronica Tisato; Paola Secchiero
|
10.2174/092986712803341548
|
12
|
60 |
Dipeptide inhibitors of thermolysin and angiotensin I-converting enzyme.
|
Current Topics In Medicinal Chemistry
|
Mahmud Tareq Hassan Khan; Kenichi Dedachi; Toshiro Matsui; Noriyuki Kurita; Monica Borgatti; Roberto Gambari; Ingebrigt Sylte
|
10.2174/156802612803989246
|
5
|
61 |
TRAIL as biomarker and potential therapeutic tool for cardiovascular diseases.
|
Current Drug Targets
|
Stella Bernardi; Daniela Milani; Bruno Fabris; Paola Secchiero; Giorgio Zauli
|
10.2174/138945012802002357
|
13
|
62 |
State of art and recent developments of anti-cancer strategies based on TRAIL.
|
Recent Patents On Anti-cancer Drug Discovery
|
Stella Bernardi; Paola Secchiero; Giorgio Zauli
|
10.2174/157489212799972927
|
29
|
63 |
Structure-based analysis of the molecular recognitions between HIV-1 TAR-RNA and transcription factor nuclear factor-kappaB (NFkB).
|
Current Topics In Medicinal Chemistry
|
Mahmud Tareq Hassan Khan; Carlo Mischiati; Arjumand Ather; Tatsuya Ohyama; Kenichi Dedachi; Monica Borgatti; Noriyuki Kurita; Roberto Gambari
|
10.2174/156802612800166800
|
11
|
64 |
GPCR heteromers and their allosteric receptor-receptor interactions.
|
Current Medicinal Chemistry
|
Kjell Fuxe; Dasiel O. Borroto-Escuela; Daniel Marcellino; Wilber Romero-Fernandez; Małgorzata Frankowska; Diego Guidolin; Małgorzata Filip; Luca Ferraro; A. Woods; Alexander O. Tarakanov; Francisco Ciruela; L. F. Agnati; Sergio Tanganelli
|
10.2174/092986712803414259
|
67
|
65 |
Low molecular weight heparins and glomerular filtration rate: a report to be considered.
|
Current Vascular Pharmacology
|
Fabio Fabbian; Alfredo De Giorgi; Marco Pala; Ruana Tiseo; Francesco Portaluppi; Davide Imberti; Roberto Manfredini
|
10.2174/157016111797484170
|
6
|
66 |
microRNA Involvement in Hepatocellular Carcinoma
|
Anti-cancer Agents In Medicinal Chemistry
|
Massimo Negrini; Laura Gramantieri; Silvia Sabbioni; Carlo M. Croce
|
10.2174/187152011796011037
|
88
|
67 |
Clinical and Rehabilitative Management of Retinitis Pigmentosa: Up-to-Date.
|
Current Genomics
|
Francesco Parmeggiani; Giovanni Sato; Katia De Nadai; Mario Romano; Andrea Binotto; Ciro Costagliola
|
10.2174/138920211795860125
|
25
|
68 |
Therapeutic challenges to retinitis pigmentosa: from neuroprotection to gene therapy.
|
Current Genomics
|
Jayashree Sahni; Martina Angi; Cristina Irigoyen; Francesco Semeraro; Mario Romano; Francesco Parmeggiani
|
10.2174/138920211795860062
|
50
|
69 |
Fine Tuning of Protein Kinase C (PKC) Isoforms in Cancer: Shortening the Distance from the Laboratory to the Bedside
|
Mini Reviews In Medicinal Chemistry
|
Raffaella Bosco; Elisabetta Melloni; Claudio Celeghini; E. Rimondi; Mauro Vaccarezza; Giorgio Zauli
|
10.2174/138955711795049899
|
46
|
70 |
Recent advances in the therapeutic perspectives of Nutlin-3.
|
Current Pharmaceutical Design
|
Paola Secchiero; Raffaella Bosco; Claudio Celeghini; Giorgio Zauli
|
10.2174/138161211795222586
|
137
|
71 |
Pharmacogenetic Aspects in Therapeutic Management of Subfoveal Choroidal Neovascularisation: Role of Factor XIII-A 185 T-Allele
|
Current Drug Targets
|
Francesco Parmeggiani; Ciro Costagliola; Carlo Incorvaia; Adolfo Sebastiani; Donato Gemmati
|
10.2174/138945011794182773
|
13
|
72 |
Synthesis and cellular pharmacology studies of a series of 2-amino-3-aroyl-4-substituted thiophene derivatives
|
Medicinal Chemistry (Shariqah (United Arab Emirates))
|
Romeo Romagnoli; Pier Giovanni Baraldi; Maria Giovanna Pavani; Olga Cruz-Lopez; Ernest Hamel; Jan Balzarini; Eleonora Brognara; Cristina Zuccato; Roberto Gambari
|
10.2174/157340610793563974
|
5
|
73 |
Glucocorticoid receptors and bone.
|
Current Pharmaceutical Design
|
Renato La Corte; Francesco Trotta; Silvano Adami
|
10.2174/138161210793797924
|
13
|
74 |
Use of glucocorticoids in pregnancy.
|
Current Pharmaceutical Design
|
Laura Lunghi; Barbara Pavan; Carla Biondi; R. Paolillo; A. Valerio; Fortunato Vesce; A. Patella
|
10.2174/138161210793797898
|
28
|
75 |
Allosteric enhancers of A1 adenosine receptors: state of the art and new horizons for drug development.
|
Current Medicinal Chemistry
|
Romeo Romagnoli; Pier Giovanni Baraldi; Mojgan Aghazadeh Tabrizi; Stefania Gessi; Pier Andrea Borea; Stefania Merighi
|
10.2174/092986710792927831
|
37
|
76 |
Concerns and Hopes for Stem Cell Therapy in Cardiology: Focus on Endothelial Progenitor Cells
|
Cardiovascular & Hematological Disorders Drug Targets
|
Roberto Ferrari; Carlo Alberto Beltrami; Luigi Tavazzi
|
10.2174/1871529x11006030216
|
5
|
77 |
Synthesis and Evaluation of Haloacetyl, α-Bromoacryloyl and Nitrooxyacetyl Benzo[b]furan and Benzo[b]thiophene Derivatives as Potent Antiproliferative Agents Against Leukemia L1210 and K562 Cells
|
Letters In Drug Design & Discovery
|
Romeo Romagnoli; Pier Giovanni Baraldi; Carlota Lopez Cara; Casolari A; Ernest Hamel; Enrica Fabbri; Roberto Gambari
|
10.2174/157018010791526296
|
5
|
78 |
HSV Recombinant Vectors for Gene Therapy
|
The Open Virology Journal
|
Roberto Manservigi; Rafaela Argnani; Peggy Marconi
|
10.2174/1874357901004010123
|
74
|
79 |
Type 2 Diabetes and Risk for Functional Decline and Disability in Older Persons
|
Current Diabetes Reviews
|
Stefano Volpato; Cinzia Maraldi; Renato Fellin
|
10.2174/157339910791162961
|
66
|
80 |
Patient opinions on the helpfulness of external rehabilitative activities in residential psychiatric care: a pilot study.
|
Clinical Practice And Epidemiology In Mental Health : CP & EMH
|
Bruno Biancosino; Luciana Marmai; Federica Marchesini; Raffaella Bertasi; Gino Targa; Raffaella Bivi; Alessandro Cucchi; Luigi Grassi
|
10.2174/1745017901006010016
|
1
|
81 |
The Role of Polyunsaturated Fatty Acids (PUFA) in the Treatment of Dyslipidemias
|
Current Pharmaceutical Design
|
Giovanni Zuliani; M. Galvani; E. Leitersdorf; Stefano Volpato; Margherita Cavalieri; Renato Fellin
|
10.2174/138161209789909773
|
51
|
82 |
Emerging Evidence for Neurotensin Receptor 1 Antagonists as Novel Pharmaceutics in Neurodegenerative Disorders
|
Mini Reviews In Medicinal Chemistry
|
Luca Ferraro; Maria Cristina Tomasini; Sarah Beggiato; Remo Guerrini; S. Salvadori; Kjell Fuxe; Laura Calzà; Sergio Tanganelli; Tiziana Antonelli
|
10.2174/138955709789957495
|
19
|
83 |
Venous collateral circulation of the extracranial cerebrospinal outflow routes.
|
Current Neurovascular Research
|
Paolo Zamboni; Giuseppe Consorti; Roberto Galeotti; Sergio Gianesini; Erica Menegatti; Giovanna Tacconi; Francesco Carinci
|
10.2174/156720209788970054
|
94
|
84 |
Predictive role of gene polymorphisms affecting thrombin-generation pathway in variable efficacy of photodynamic therapy for neovascular age-related macular degeneration.
|
Recent Patents On DNA & Gene Sequences
|
Francesco Parmeggiani; Donato Gemmati; Ciro Costagliola; Adolfo Sebastiani; Carlo Incorvaia
|
10.2174/187221509788654151
|
9
|
85 |
Exposure of B cell chronic lymphocytic leukemia (B-CLL) cells to nutlin-3 induces a characteristic gene expression profile, which correlates with nutlin-3-mediated cytotoxicity.
|
Current Cancer Drug Targets
|
Giorgio Zauli; M. G. Di Iasio; Paola Secchiero; M. Dal Bo; D. Marconi; Riccardo Bomben; G. Del Poeta; Valter Gattei
|
10.2174/156800909788486777
|
10
|
86 |
Discovery of 8-methoxypyrazino[1,2-a]indole as a New Potent Antiproliferative Agent Against Human Leukemia K562 Cells. A Structure-Activity Relationship Study
|
Letters In Drug Design & Discovery
|
Romeo Romagnoli; Pier Giovanni Baraldi; Maria Dora Carrion; Olga Cruz-Lopez; Carlota Lopez Cara; Delia Preti; Mojgan Aghazadeh Tabrizi; Jan Balzarini; Ernest Hamel; Enrica Fabbri; Roberto Gambari
|
10.2174/157018009788452519
|
11
|
87 |
Perspectives of protein kinase C (PKC) inhibitors as anti-cancer agents.
|
Mini Reviews In Medicinal Chemistry
|
Arianna Gonelli; Carlo Mischiati; Remo Guerrini; Rebecca Voltan; Severo Salvadori; Giorgo Zauli
|
10.2174/138955709787847967
|
41
|
88 |
Influence of lifestyle measures on hypertriglyceridaemia.
|
Current Drug Targets
|
Fabio Manfredini; Sergio D'Addato; Luca Laghi; A. M. Malagoni; Simona Mandini; Benedetta Boari; Claudio Borghi; Roberto Manfredini
|
10.2174/138945009787846407
|
6
|
89 |
α-Halogenoacrylic Derivatives of Antitumor Agents
|
Mini Reviews In Medicinal Chemistry
|
Romeo Romagnoli; Pier Giovanni Baraldi; Olga Cruz-Lopez; Carlota Lopez-Cara; Delia Preti
|
10.2174/138955709787001640
|
13
|
90 |
Synthesis and Biological Evaluation of 2-aroyl-4-phenyl-5- hydroxybenzofurans as a New Class of Antitubulin Agents
|
Medicinal Chemistry (Shariqah (United Arab Emirates))
|
Romeo Romagnoli; Pier Giovanni Baraldi; Taradas Sarkar; Carlota Lopez Cara; Olga Cruz Lopez; Maria Dora Carrion; Delia Preti; Manlio Tolomeo; Jan Balzarini; Ernest Hamel
|
10.2174/157340608786242007
|
9
|
91 |
Doppler haemodynamics of cerebral venous return.
|
Current Neurovascular Research
|
Erica Menegatti; Paolo Zamboni
|
10.2174/156720208786413442
|
59
|
92 |
Potential role of PKC inhibitors in the treatment of hematological malignancies.
|
Current Pharmaceutical Design
|
Carlo Mischiati; Elisabetta Melloni; Federica Corallini; Daniela Milani; Carlo M. Bergamini; Mauro Vaccarezza
|
10.2174/138161208785294618
|
7
|
93 |
The MDM2 inhibitor Nutlins as an innovative therapeutic tool for the treatment of haematological malignancies.
|
Current Pharmaceutical Design
|
Paola Secchiero; Maria Grazia di Iasio; Arianna Gonelli; Giorgio Zauli
|
10.2174/138161208785294663
|
77
|
94 |
HLA-G and Inflammatory Diseases
|
Inflammation & Allergy Drug Targets
|
Olavio R. Baricordi; Marina Stignani; Loredana Melchiorri; Roberta Rizzo
|
10.2174/187152808785107615
|
57
|
95 |
Under the microscope: focus on Chlamydia pneumoniae infection and multiple sclerosis.
|
Current Neurovascular Research
|
Enrico Fainardi; Massimiliano Castellazzi; Silva Seraceni; Enrico Granieri; Carlo Contini
|
10.2174/156720208783565609
|
32
|
96 |
Synthesis and Biological Evaluation of 2-amino-3-(3, 4, 5-trimethoxyphenylsulfonyl)-5-aryl thiophenes as a New Class of Antitubulin Agents
|
Medicinal Chemistry (Shariqah (United Arab Emirates))
|
Romeo Romagnoli; Pier Giovanni Baraldi; Vincent Remusat; Maria Dora Carrion; Carlota Lopez Cara; Olga Cruz-Lopez; Delia Preti; Francesca Fruttarolo; Mojgan Aghazadeh Tabrizi; Jan Balzarini; Ernest Hamel
|
10.2174/157340607782360380
|
3
|
97 |
Intracranial venous haemodynamics in multiple sclerosis
|
Current Neurovascular Research
|
Paolo Zamboni; Erica Menegatti; Ilaria Bartolomei; Roberto Galeotti; Anna Maria Malagoni; Giovanna Tacconi; Fabrizio Salvi
|
10.2174/156720207782446298
|
112
|
98 |
Synergistic cytotoxic activity of recombinant TRAIL plus the non-genotoxic activator of the p53 pathway nutlin-3 in acute myeloid leukemia cells.
|
Current Drug Metabolism
|
Paola Secchiero; Carlotta Zerbinati; Maria Grazia di Iasio; Elisabetta Melloni; Mario Tiribelli; Vittorio Grill; Giorgio Zauli
|
10.2174/138920007780655432
|
61
|
99 |
SV40 and HIV sequences in the cerebrospinal fluid of a patient with AIDS dementia complex.
|
Current HIV Research
|
Manola Comar; Pierlanfranco D'Agaro; Roberto Luzzati; Fernanda Martini; Mauro Tognon; Cesare Campello
|
10.2174/157016207780636560
|
1
|
100 |
Medicinal chemistry of fetal hemoglobin inducers for treatment of beta-thalassemia.
|
Current Medicinal Chemistry
|
Roberto Gambari; Eitan Fibach
|
10.2174/092986707779313318
|
80
|
101 |
Ligands for A2B adenosine receptor subtype.
|
Current Medicinal Chemistry
|
Pier Giovanni Baraldi; Romeo Romagnoli; Delia Preti; Francesca Fruttarolo; Maria DoraCarrion; Mojgan Aghazadeh Tabrizi
|
10.2174/092986706779010306
|
16
|
102 |
Nuclear retinoic acid receptor beta as a tool in chemoprevention trials.
|
Current Medicinal Chemistry
|
Barbara Pavan; Carla Biondi; Alessandro Dalpiaz
|
10.2174/092986706779026183
|
16
|
103 |
Molecular mechanisms of respiratory virus-induced asthma and COPD exacerbations and pneumonia.
|
Current Medicinal Chemistry
|
Gaetano Caramori; Kazuhiro Ito; Marco Contoli; Antonino Di Stefano; Sebastian L. Johnston; Ian M. Adcock; Alberto Papi
|
10.2174/092986706777935159
|
23
|
104 |
Frailty of older age: the role of the endocrine--immune interaction.
|
Current Pharmaceutical Design
|
Roberto Paganelli; A. Di Iorio; Antonio Cherubini; Fabrizio Lauretani; Chiara Mussi; Stefano Volpato; Michele Abate; G. Abate; Luigi Ferrucci
|
10.2174/138161206777947533
|
44
|
105 |
Natural and synthetic retinoids: Structural bases and biological effects of potential clinical relevance for the prevention and treatment of infection-driven tumors
|
Anti-Infective Agents In Medicinal Chemistry
|
Riccardo Dolcetti; Dario Di Luca; Angel R. de Lera
|
10.2174/187152106774755617
|
1
|
106 |
Transglutaminase and vascular biology: physiopathologic implications and perspectives for therapeutic interventions.
|
Current Medicinal Chemistry
|
Carlo M. Bergamini; Martin Griffin; Francesco Pansini
|
10.2174/0929867054864804
|
21
|
107 |
Pyrazolo[4,3-e]1,2,4-triazolo[1,5-c]pyrimidine ligands, new tools to characterize A3 adenosine receptors in human tumor cell lines.
|
Current Medicinal Chemistry
|
Pier Giovanni Baraldi; Mojgan Aghazadeh Tabrizi; Romeo Romagnoli; Francesca Fruttarolo; Stefania Merighi; Katia Varani; Stefania Gessi; Pier Andrea Borea
|
10.2174/0929867054020963
|
30
|
108 |
The role and modulation of the oxidative balance in pregnancy.
|
Current Pharmaceutical Design
|
Carla Biondi; Barbara Pavan; Laura Lunghi; Sara Fiorini; Fortunato Vesce
|
10.2174/1381612054065747
|
45
|
109 |
Management of the menopausal disturbances and oxidative stress.
|
Current Pharmaceutical Design
|
Francesco Pansini; Gioacchino Mollica; Carlo M. Bergamini
|
10.2174/1381612054065819
|
24
|
110 |
Oxidative stress, antioxidants and neurodegenerative diseases.
|
Current Pharmaceutical Design
|
Ilaria Casetta; Vittorio Govoni; Enrico Granieri
|
10.2174/1381612054065729
|
112
|
111 |
Targeting kinin receptors for the treatment of neurological diseases.
|
Current Pharmaceutical Design
|
Donata Rodi; R. Couture; B. Ongali; Michele Simonato
|
10.2174/1381612053507422
|
44
|
112 |
Leukocyte P2 receptors: a novel target for anti-inflammatory and anti-tumor therapy.
|
Current Drug Targets. Cardiovascular & Haematological Disorders
|
Francesco Di Virgilio; O. Roberto Baricordi; Romeo Romagnoli; Pier Giovanni Baraldi
|
10.2174/1568006053004967
|
48
|
113 |
Agonists and antagonists acting at P2X7 receptor.
|
Current Topics In Medicinal Chemistry
|
Pier Giovanni Baraldi; Francesco Di Virgilio; Romeo Romagnoli
|
10.2174/1568026043387223
|
79
|
114 |
TNF-related apoptosis-inducing ligand (TRAIL): a potential candidate for combined treatment of hematological malignancies.
|
Current Pharmaceutical Design
|
Paola Secchiero; Mauro Vaccarezza; Arianna Gonelli; Giorgio Zauli
|
10.2174/1381612043382747
|
42
|
115 |
In vivo imaging of oligonucleotides with nuclear tomography.
|
Current Drug Targets
|
Adriano Duatti
|
10.2174/1389450043345119
|
11
|
116 |
Recent advances in the development of HIV-1 Tat-based vaccines.
|
Current HIV Research
|
Antonella Caputo; Riccardo Gavioli; Barbara Ensoli
|
10.2174/1570162043350986
|
48
|
117 |
6-Phosphogluconate Dehydrogenase: A Target for Drugs in African Trypanosomes
|
Current Medicinal Chemistry
|
Stefania Hanau; Eliana Rinaldi; Franco Dallocchio; Ian H. Gilbert; Christophe Dardonville; Margaret J. Adams; Sheila Gover; Michael P. Barrett
|
10.2174/0929867043364441
|
26
|
118 |
Oxygen, Reactive Oxygen Species and Tissue Damage
|
Current Pharmaceutical Design
|
Carlo M. Bergamini; Stefania Gambetti; Alessia Dondi; Carlo Cervellati
|
10.2174/1381612043384664
|
455
|
119 |
New pathways for reactive oxygen species generation in inflammation and potential novel pharmacological targets.
|
Current Pharmaceutical Design
|
F Di Virgilio
|
10.2174/1381612043384727
|
58
|
120 |
Oxidative stress in essential hypertension.
|
Current Pharmaceutical Design
|
Francesco Portaluppi; Benedetta Boari; Roberto Manfredini
|
10.2174/1381612043384619
|
65
|
121 |
Oxidative Stress During Myocardial Ischaemia and Heart Failure
|
Current Pharmaceutical Design
|
Roberto Ferrari; Gabriele Guardigli; Donato Mele; Gianfranco Percoco; Claudio Ceconi; Salvatore Curello
|
10.2174/1381612043384718
|
202
|
122 |
The Antioxidants and Pro-Antioxidants Network: An Overview
|
Current Pharmaceutical Design
|
Silvia Vertuani; Angela Angusti; Stefano Manfredini
|
10.2174/1381612043384655
|
311
|
123 |
Antagonism in opioid peptides: the role of conformation.
|
Current Topics In Medicinal Chemistry
|
Severo Salvadori; Piero A. Temussi
|
10.2174/1568026043451564
|
14
|
124 |
Receptor binding thermodynamics at the neuronal nicotinic receptor.
|
Current Topics In Medicinal Chemistry
|
P.A. Borea; K. Varani; Stefania Merighi; A.D. Piaz; P. Gilli; G. Gilli
|
10.2174/1568026043451410
|
21
|
125 |
Distamycin A as stem of DNA minor groove alkylating agents.
|
Current Topics In Medicinal Chemistry
|
Pier Giovanni Baraldi; Maria del Carmen Nuñez; Antonio Espinosa; Romeo Romagnoli
|
10.2174/1568026043451474
|
11
|
126 |
The Bovine Basic Pancreatic Trypsin Inhibitor (Kunitz Inhibitor): A Milestone Protein
|
Current Protein & Peptide Science
|
Paolo Ascenzi; Alessio Bocedi; Martino Bolognesi; Andrea Spallarossa; Massimo Coletta; Raimondo De Cristofaro; Enea Menegatti
|
10.2174/1389203033487180
|
133
|
127 |
Studies on human neutrophil biological functions by means of formyl-peptide receptor agonists and antagonists.
|
Current Drug Targets. Immune, Endocrine And Metabolic Disorders
|
Alessandro Dalpiaz; Susanna Spisani; Carla Biondi; Elena Fabbri; M Nalli; Maria Enrica Ferretti
|
10.2174/1568008033340333
|
48
|
128 |
Medicinal chemistry of A2A adenosine receptor antagonists.
|
Current Topics In Medicinal Chemistry
|
Barbara Cacciari; Giorgia Pastorin; Giampiero Spalluto
|
10.2174/1568026033392183
|
32
|
129 |
Pyrazolo-triazolo-pyrimidine derivatives as adenosine receptor antagonists: a possible template for adenosine receptor subtypes?
|
Current Pharmaceutical Design
|
Pier Giovanni Baraldi; Barbara Cacciari; Pier Andrea Borea; Katia Varani; Giorgia Pastorin; Tatiana Da Ros; Mojgan Aghazadeh Tabrizi; Francesca Fruttarolo; Giampiero Spalluto
|
10.2174/1381612023392838
|
17
|
130 |
Retinoids, apoptosis and cancer.
|
Current Pharmaceutical Design
|
Daniele Simoni; Manlio Tolomeo
|
10.2174/1381612013397168
|
66
|
131 |
Distamycins: strategies for possible enhancement of activity and specificity.
|
Mini Reviews In Medicinal Chemistry
|
Rita Cortesi; Elisabetta Esposito
|
|
10
|
132 |
Heterocyclic analogs of DNA minor groove alkylating agents.
|
Current Pharmaceutical Design
|
Pier Giovanni Baraldi; Barbara Cacciari; Andrea Guiotto; R. Romagnoli; Abdel Naser Zaid; Giampiero Spalluto
|
|
9
|